Moreover, studies have indicated that patients with phenylketonuria (PKU), a rare disorder characterized by cranial nerve damage due to abnormal phenylacetone metabolism, exhibit elevated levels of Aβ1-42 and tau in the cerebrospinal fluid (CSF) [38]. This evidence concerns the gene MAPT and phenylketonuria.